Journal of Cardiac Failure
Volume 16, Issue 6 , Pages 454-460 , June 2010

Assessment of Cost and Health Resource Utilization for Elderly Patients With Heart Failure and Diabetes Mellitus

  • Hillary R. Bogner, MD, MSCE

      Affiliations

    • Department of Family Medicine and Community Health, University of Pennsylvania, Philadelphia, PA
    • Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA
    • Corresponding Author InformationReprint requests: Hillary R. Bogner, MD, MSCE, Assistant Professor, Department of Family Medicine and Community Health, The University of Pennsylvania, 3400 Spruce Street, 2 Gates Building, Philadelphia, PA 19104. Tel: 215-615-0851; Fax: 215-662-3591.
    • ,
  • Steven D. Miller, BS

      Affiliations

    • Department of Family Medicine and Community Health, University of Pennsylvania, Philadelphia, PA
    • ,
  • Heather F. de Vries, MSPH, CPH

      Affiliations

    • Department of Family Medicine and Community Health, University of Pennsylvania, Philadelphia, PA
    • Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA
    • ,
  • Sumedha Chhatre, PhD

      Affiliations

    • Department of Psychiatry, University of Pennsylvania, Philadelphia, PA
    • ,
  • Ravishankar Jayadevappa, PhD

      Affiliations

    • Department of Medicine, Division of Geriatric Medicine, University of Pennsylvania, Philadelphia, PA
    • Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA

Received 2 October 2009 ,Revised 6 January 2010 ,Accepted 27 January 2010.

References 

  1. Cohen-Solal A, Beauvais F, Logeart D. Heart failure and diabetes mellitus: epidemiology and management of an alarming association. J Cardiac Failure. 2008;14:615–625
  2. Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, et al. Heart disease and stroke statistics—2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. [erratum appears in Circulation. 2007 Feb 6;115(5):e172] Circulation. 2007;115:e69–171
  3. Narayan KM, Boyle JP, Geiss LS, Saaddine JB, Thompson TJ. Impact of recent increase in incidence on future diabetes burden: U.S., 2005-2050. Diabetes Care. 2006;29:2114–2116
  4. Shindler DM, Kostis JB, Yusuf S, Quinones MA, Pitt B, Stewart D, et al. Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry. Am J Cardiol. 1996;77:1017–1020
  5. Zannad F, Briancon S, Juilliere Y, Mertes PM, Villemot JP, Alla F, et al. Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL Study. Epidemiologie de l'Insuffisance Cardiaque Avancee en Lorraine. J Am Coll Cardiol. 1999;33:734–742
  6. Cohen-Solal A, Desnos M, Delahaye F, Emeriau JP, Hanania G. A national survey of heart failure in French hospitals. The Myocardiopathy and Heart Failure Working Group of the French Society of Cardiology, the National College of General Hospital Cardiologists and the French Geriatrics Society. Eur Heart J. 2000;21:763–769
  7. Yancy CW, Lopatin M, Stevenson LW, De Marco T, Fonarow GC. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J Am Coll Cardiol. 2006;47:76–84
  8. Adams KF, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, Abraham WT, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2005;149:209–216
  9. Cleland JG, Swedberg K, Follath F, Komajda M, Cohen-Solal A, Aguilar JC, et al. The EuroHeart Failure survey programme—a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J. 2003;24:442–463
  10. Iribarren C, Karter AJ, Go AS, Ferrara A, Liu JY, Sidney S, et al. Glycemic control and heart failure among adult patients with diabetes. Circulation. 2001;103:2668–2673
  11. Avendano GF, Agarwal RK, Bashey RI, Lyons MM, Soni BJ, Jyothirmayi GN, et al. Effects of glucose intolerance on myocardial function and collagen-linked glycation. Diabetes. 1999;48:1443–1447
  12. de Groote P, Lamblin N, Mouquet F, Plichon D, McFadden E, Van Belle E, et al. Impact of diabetes mellitus on long-term survival in patients with congestive heart failure. Eur Heart J. 2004;25:656–662
  13. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA. 1979;241:2035–2038
  14. Liu J, Masurekar MR, Vatner DE, Jyothirmayi GN, Regan TJ, Vatner SF, et al. Glycation end-product cross-link breaker reduces collagen and improves cardiac function in aging diabetic heart. Am J Physiol Heart Circ Physiol. 2003;285:H2587–H2591
  15. Shindler DM, Kostis JB, Yusuf S, Quinones MA, Pitt B, Stewart D, et al. Diabetes mellitus, a predictor of morbidity and mortality in the studies of left ventricular dysfunction (SOLVD) trials and registry. Am J Cardiol. 1996;77:1017–1020
  16. Nichols GA, Gullion CM, Koro CE, Ephross SA, Brown JB. The incidence of congestive heart failure in type 2 diabetes: an update. Diabetes Care. 2004;27:1879–1884
  17. Held C, Gerstein HC, Yusuf S, Zhao F, Hilbrich L, Anderson C, et al. Glucose levels predict hospitalization for congestive heart failure in patients at high cardiovascular risk. Circulation. 2007;115:1371–1375
  18. Dries DL, Sweitzer NK, Drazner MH, Stevenson LW, Gersh BJ. Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction. J Am Coll Cardiol. 2001;38:421–428
  19. De Groote P, Lamblin N, Mouquet F, Plichon D, McFadden E, Van Belle E, et al. Impact of diabetes mellitus on long-term survival in patients with congestive heart failure. Eur Heart J. 2004;25:656–662
  20. Domanski M, Krause-Steinrauf H, Deedwania P, Follmann D, Ghali JK, Gilbert E, et al. The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trial. J Am Coll Cardiol. 2003;42:914–922
  21. Pocock SJ, Wang D, Pfeffer MA, Yusuf S, McMurray JJ, Swedberg KB, et al. Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J. 2006;27:65–75
  22. From AM, Leibson CL, Bursi F, Redfield MM, Weston SA, Jacobsen SJ, et al. Diabetes in heart failure: prevalence and impact on outcome in the population. Am J Med. 2006;119:591–599
  23. Varela-Roman A, Shamagian LG, Caballero EB, Ramos PM, Veloso PR, Gonzalez-Juanatey JR. Influence of diabetes on the survival of patients hospitalized with heart failure: a 12-year study. Eur J Heart Fail. 2005;7:859–864
  24. Andrews RM. The National Hospital Bill: the most expensive conditions by payer, 2006. HCUP Statistical Brief # 59 2008. Available from: http://www.hcup-us.ahrq.gov/reports/statbriefs/sb59.pdf.
  25. Russo MJ, Gelijns AC, Stevenson LW, Sampat B, Aaronson KD, Renlund DG, et al. The cost of medical management in advanced heart failure during the final two years of life. [see comment] J Cardiac Failure. 2008;14:651–658
  26. Masoudi FA, Baillie CA, Wang Y, Bradford WD, Steiner JF, Havranek EP, et al. The complexity and cost of drug regimens of older patients hospitalized with heart failure in the United States, 1998-2001. Arch Intern Med. 2005;165:2069–2076
  27. Liao L, Allen LA, Whellan DJ. Economic burden of heart failure in the elderly. Pharmacoeconomics. 2008;26447–26462
  28. Pelletier EM, Smith PJ, Boye KS, Misurski DA, Tunis SL, Minshall ME. Direct medical costs for type 2 diabetes mellitus complications in the US commercial payer setting: a resource for economic research. Appl Health Econ Health Pol. 2008;6:103–112
  29. Brandle M, Zhou H, Smith BRK, Marriott D, Burke R, Tabaei BP, et al. The direct medical cost of type 2 diabetes. Diabetes Care. 2003;26:2300–2304
  30. Ettaro L, Songer TJ, Zhang P, Engelgau MM. Cost-of-illness studies in diabetes mellitus. PharmacoEconomics. 2004;22:149–164
  31. Morsanutto A, Berto P, Lopatriello S, Gelisio R, Voinovich D, Cippo PP, et al. Major complications have an impact on total annual medical cost of diabetes: results of a database analysis. J Diabetes Complications. 2006;20:163–169
  32. Titler MG, Jensen GA, Dochterman JM, Xie X-J, Kanak M, Reed D, et al. Cost of hospital care for older adults with heart failure: medical, pharmaceutical, and nursing costs. Health Serv Res. 2008;43:635–655
  33. Stewart S, Jenkins A, Buchan S, McGuire A, Capewell S, McMurray JJ. The current cost of heart failure to the National Health Service in the UK. Eur J Heart Fail. 2002;4:361–371
  34. Weintraub WS, Kawabata H, Tran M, L'Italien GJ, Chen RS. Influence of co-morbidity on cost of care for heart failure. Am J Cardiol. 2003;91:1011–1015
  35. Gilmer TP, O'Connor PJ, Rush WA, Crain AL, Whitebird RR, Hanson AM, et al. Predictors of health care costs in adults with diabetes. Diabetes Care. 2005;28:59–64
  36. Clarke P, Gray A, Legood R, Briggs A, Holman R. The impact of diabetes-related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65). Diabetic Med. 2003;20:442–450
  37. Clarke P, Leal J, Kelman C, Smith M, Colagiuri S. Estimating the cost of complications of diabetes in Australia using administrative health-care data. Value Health. 2008;11:199–206
  38. Gerdtham U-G, Clarke P, Hayes A, Gudbjornsdottir S. Estimating the cost of diabetes mellitus-related events from inpatient admissions in Sweden using administrative hospitalization data. Pharmacoeconomics. 2009;27:81–90
  39. Williams R, Van Gaal L, Lucioni C, Board C-A. Assessing the impact of complications on the costs of Type II diabetes. Diabetologia. 2002;45:S13–S17
  40. Gandra SR, Lawrence LW, Parasuraman BM, Darin RM, Sherman JJ, Wall JL. Total and component health care costs in a non-Medicare HMO population of patients with and without type 2 diabetes and with and without macrovascular disease. J Manage Care Pharmacy. 2006;12:546–554
  41. Agvall B, Borgquist L, Foldevi M, Dahlstrom U. Cost of heart failure in Swedish primary healthcare. Scand J Primary Health Care. 2005;23:227–232
  42. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383
  43. O'Brien JA, Patrick AR, Caro J. Estimates of direct medical costs for microvascular and macrovascular complications resulting from type 2 diabetes mellitus in the United States in 2000. Clin Therapeutics. 2003;25:1017–1038
  44. Caro JJ, Ward AJ, O'Brien JA. Lifetime costs of complications resulting from type 2 diabetes in the U.S. Diabetes Care. 2002;25:476–481
  45. software S. Version 9.1. SAS Institute Inc; Cary, NC.
  46. Greene WH. Economic analysis. 4th edition. Upper Saddle River, NJ: Prentice-Hall, Inc.; 2000;
  47. Weintraub WS, Deaton C, Shaw L, Mahoney E, Morris DC, Saunders C, et al. Can cardiovascular clinical characteristics be identified and outcome models be developed from an in-patient claims database?. Am J Cardiol. 1999;84:166–169
  48. Hannan EL, Kilburn H, Lindsey ML, Lewis R. Clinical versus administrative data bases for CABG surgery. Does it matter?. Med Care. 1992;30:892–907
  49. Thorpe KE, Howard DH. The rise in spending among Medicare beneficiaries: the role of chronic disease prevalence and changes in treatment intensity. [see comment] Health Affairs. 2006;25:w378–w388
  50. Ware MG, Flavell CM, Lewis EF, Nohria A, Warner-Stevenson L, Givertz MM. Heart failure and diabetes: collateral benefit of chronic disease management. Congest Heart Fail. 2006;12:132–136
  51. Hebert PL, Sisk JE, Wang JJ, Tuzzio L, Casabianca JM, Chassin MR, et al. Cost-effectiveness of nurse-led disease management for heart failure in an ethnically diverse urban community. Ann Intern Med. 2008;149:540–548
  52. McCauley KM, Bixby MB, Naylor MD. Advanced practice nurse strategies to improve outcomes and reduce cost in elders with heart failure. Dis Manage. 2006;9:302–310

 See page 458 for disclosure information.

 Supported by an American Diabetes Association Clinical Research Award and an American Heart Association Grant-in-Aid.

PII: S1071-9164(10)00047-3

doi: 10.1016/j.cardfail.2010.01.007

Journal of Cardiac Failure
Volume 16, Issue 6 , Pages 454-460 , June 2010

Article Tools